Status:
COMPLETED
Lipoarabinomannan (LAM) in Urine for Diagnosis of Pulmonary Tuberculosis in HIV Patients
Lead Sponsor:
Mansoura University
Conditions:
TB - Tuberculosis HIV
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A diagnostic validity study in which urinary LAM was done in seropositive HIV patients with symptoms suggestive of TB who were included and investigated with battery of tests to reach the final diagno...
Detailed Description
A diagnostic validity study in which urinary LAM was done in seropositive HIV patients with symptoms suggestive of TB who were included and investigated with battery of tests to reach the final diagno...
Eligibility Criteria
Inclusion
- The study included seropositive HIV patients with a new diagnosis of either pulmonary or extra-pulmonary TB, and also included patients who were presented by symptoms suggestive for tuberculosis, changes in chest X ray that not improved by full course of antibiotics or positive tuberculin test ≥ 5 mm.
Exclusion
- Patients on anti-TB drugs or negative screening for sero-positive HIV patients were excluded from the study.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT04813666
Start Date
January 1 2015
End Date
October 1 2016
Last Update
March 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.